These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35498044)

  • 1. Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds-Insights From an All-Comer Registry.
    Bossard M; Madanchi M; Avdijaj D; Attinger-Toller A; Cioffi GM; Seiler T; Tersalvi G; Kobza R; Schüpfer G; Cuculi F
    Front Cardiovasc Med; 2022; 9():856930. PubMed ID: 35498044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry.
    Wlodarczak A; Lanocha M; Jastrzebski A; Pecherzewski M; Szudrowicz M; Jastrzebski W; Nawrot J; Lesiak M
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E287-E292. PubMed ID: 30537203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold.
    Madanchi M; Cioffi GM; Attinger-Toller A; Wolfrum M; Moccetti F; Seiler T; Vercelli L; Burkart P; Toggweiler S; Kobza R; Bossard M; Cuculi F
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34518287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
    Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C
    Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study.
    Hommels TM; Hermanides RS; Rasoul S; Berta B; IJsselmuiden AJJ; Jessurun GAJ; Benit E; Pereira B; De Luca G; Kedhi E
    Cardiovasc Diabetol; 2019 Mar; 18(1):25. PubMed ID: 30851731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents.
    Rola P; Włodarczak A; Barycki M; Szudrowicz M; Łanocha M; Kulczycki JJ; Turkiewicz K; Woźnica K; Lesiak M; Doroszko A
    J Diabetes Res; 2021; 2021():8636050. PubMed ID: 34859105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Tovar Forero MN; van Zandvoort L; Masdjedi K; Diletti R; Wilschut J; de Jaegere PP; Zijlstra F; Van Mieghem NM; Daemen J
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):226-231. PubMed ID: 31033171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Gutiérrez-Barrios A; Gheorghe LL; Camacho Freire S; Silva E; Gómez Menchero A; Francisco Jose MP; Cañadas Pruaño D; Martínez Capoccioni U; Gomez Lara J; Bretones Del Pino T; Calle Perez G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):E69-E77. PubMed ID: 33600069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-month clinical outcomes after Magmaris percutaneous coronary intervention in a real-world cohort of patients: Results from the CardioHULA registry.
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Bayon-Lorenzo J; Santas-Alvarez M; Gonzalez-Juanatey C
    Rev Port Cardiol (Engl Ed); 2020 Aug; 39(8):421-425. PubMed ID: 32763098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single
    Wu Y; Yin J; Chen J; Yao Z; Qian J; Shen L; Ge L; Ge J
    Ann Transl Med; 2020 Sep; 8(18):1162. PubMed ID: 33241011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
    Koltowski L; Tomaniak M; Ochijewicz D; Maksym J; Roleder T; Zaleska M; Proniewska K; Opolski G; Kochman J
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):E1-E7. PubMed ID: 31343827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of bioresorbable vascular scaffold to treat all-comer patients. Are patients with acute coronary syndrome better candidates for bioresorbable vascular scaffold?
    Picard F; Avram R; Marquis-Gravel G; Tadros VX; Ly HQ; Dorval JF; Doucet S; Gosselin G; Asgar AW; Ibrahim R; Bonan R; de Hemptinne Q; Nosair M; L-L'Allier P; Tanguay JF
    Cardiovasc Revasc Med; 2019 Mar; 20(3):228-234. PubMed ID: 30075958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry.
    Rapetto C; Leoncini M; Cerrato E; Regazzoli D; Cortese B; Rossi A; Fetiveau R; Geraci S; De Angelis MC; Tespili M; Iannaccone M; Centola A; Durante A; De Carlo M; De Caterina A; Ribichini F; Favaretto E; Testa L; Pirisi R; Varbella F; Nicolini E; di Palma G; Loi B; Poli A; Caramanno G; Varricchio A; Garbo R; Cuculo A; Petronio AS; Berti S; Bollati M; Spedicato L; De Candia G; Piva T; Quadri G; Colombo A; Ielasi A
    Cardiovasc Revasc Med; 2021 Sep; 30():1-8. PubMed ID: 33077393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.
    Byrne RA; Alfonso F; Schneider S; Maeng M; Wiebe J; Kretov E; Bradaric C; Rai H; Cuesta J; Rivero F; Hoppmann P; Schlichtenmaier J; Christiansen EH; Cassese S; Joner M; Schunkert H; Laugwitz KL; Kastrati A
    Eur Heart J; 2019 Jan; 40(2):167-176. PubMed ID: 30520980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome.
    Włodarczak A; Łanocha M; Szudrowicz M; Barycki M; Gosiewska A; Kulczycki JJ; Lesiak M; Doroszko A; Rola P
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
    Brugaletta S; Cequier A; Alfonso F; Iñiguez A; Romaní S; Serra A; Salinas P; Goicolea J; Bordes P; Del Blanco BG; Hernández-Antolín R; Pernigotti A; Gómez-Lara J; Sabaté M
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):64-70. PubMed ID: 30196572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
    Ortega-Paz L; Capodanno D; Giacchi G; Gori T; Nef H; Latib A; Caramanno G; Di Mario C; Naber C; Lesiak M; Capranzano P; Wiebe J; Mehilli J; Araszkiewicz A; Pyxaras S; Mattesini A; Geraci S; Naganuma T; Colombo A; Münzel T; Sabaté M; Tamburino C; Brugaletta S
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):812-818. PubMed ID: 27515568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.
    Blachutzik F; Achenbach S; Tröbs M; Marwan M; Weissner M; Nef H; Schlundt C
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):202-207. PubMed ID: 30196573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
    Wiebe J; Hofmann FJ; Dörr O; Bauer T; Boeder N; Liebetrau C; Blachutzik F; Möllmann H; Elsässer A; Achenbach S; Hamm CW; Nef HM
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):56-62. PubMed ID: 32187817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.